Accelerate oncology drug development: A data-driven approach to clinical decisions
Bio Pharma Dive
MARCH 24, 2025
Speed vs. success in oncology trials: Discover data-driven strategies to accelerate drug development.
Mon.Mar 24, 2025
246 
AstraZeneca to invest $2.5bn in R&D centre in China
Pharmaceutical Technology
MARCH 24, 2025
AstraZeneca has announced a $2.5bn investment to establish the companys sixth worldwide strategic R&D centre in China.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Novo adds to obesity drug pipeline via $200M deal with China-based biotech
Bio Pharma Dive
MARCH 24, 2025
The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.
Tempero secures $70m to advance addiction treatment candidate
Pharmaceutical Technology
MARCH 24, 2025
TMP-301 is being investigated in clinical trials for alcohol use disorder and cocaine use disorder.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Verve gets FDA green light to expand base editing trial into US
Bio Pharma Dive
MARCH 24, 2025
The company expects next quarter to read out initial data from its Heart-2 trial, which is testing a one-time treatment for people with genetically elevated cholesterol.
Augustine secures $85m to advance Charcot-Marie-Tooth candidate
Pharmaceutical Technology
MARCH 24, 2025
Augustine Therapeutics has raised 78m ($85m) in funding to support the development of its lead candidate as it enters a Phase I/II trial in Charcot-Marie-Tooth (CMT) disease.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Alberta partners Siemens and the Alberta Cancer Foundation
Pharmaceutical Technology
MARCH 24, 2025
The government of Alberta has announced a collaboration with Siemens Healthineers and the Alberta Cancer Foundation, investing C$800m.
Biogen plots new global headquarters in Kendall Square
Bio Pharma Dive
MARCH 24, 2025
The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development project spearheaded by MIT.
FDA approves IND application for Everest’s cancer vaccine
Pharmaceutical Technology
MARCH 24, 2025
The FDA has granted approval for the IND application of Everest Medicines tumour-associated antigen (TAA) vaccine, EVM14.
23andMe files for bankruptcy as CEO Anne Wojcicki resigns
Bio Pharma Dive
MARCH 24, 2025
The DNA-testing company plans to sell its assets after the board rejected an acquisition proposal from Wojcicki.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Valneva outlays 40,000 vaccines to Réunion amidst chikungunya surge
Pharmaceutical Technology
MARCH 24, 2025
Valneva will work with local health authorities and wholesalers on the French island territory to distribute the vaccines.
Leveraging clinical and financial data sets to guide investment strategies in 2025’s biopharma market
Bio Pharma Dive
MARCH 24, 2025
Understanding private sector breakthroughs, acquisitions and funding is critical in a volatile market.
Rising Sirturo resistance highlights urgent need for new TB therapies
Pharmaceutical Technology
MARCH 24, 2025
Today marks World TB Day 2025 with the WHO calling for more investment into TB treatment and research globally.
23andMe files for bankruptcy protection
pharmaphorum
MARCH 24, 2025
DNA testing specialist 23andMe has filed for bankruptcy and co-founder and chief executive Anne Wojcicki has stepped down.
WHO adds first maternal RSV vaccine to prequalification list
Pharma Times
MARCH 24, 2025
Pfizers Abrysvo is designed to prevent RSV-associated disease in infants
Novo Nordisk looks east for another obesity therapy
pharmaphorum
MARCH 24, 2025
Novo Nordisk has moved to shore up its obesity pipeline with a $2bn licensing deal for a triple agonist developed by China's United Biotechnology
PAP 2025: The Unfinished Work of Healthcare Reform
Pharmaceutical Commerce
MARCH 24, 2025
Jonathan James, CEO, Hope Charities, discusses how, despite policy advancements, millions of people still face barriers to healthcare access.
MIT team develops 'years-long' drug delivery tech
pharmaphorum
MARCH 24, 2025
Researchers in the US have devised a new depot system that could provide months or even years of delivery from a single subcutaneous injection.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Pulse 3/24/25: Strategies to Address Rising Medication Costs, Optum Rx Changes How Pharmacies Are Reimbursed & more
Pharmaceutical Commerce
MARCH 24, 2025
The latest news for pharma industry insiders.
Phase 3 readout puts Opthea at risk of insolvency
pharmaphorum
MARCH 24, 2025
After its lead wet AMD drug failed a phase 3 trial, Opthea may have to make massive repayments to investors that would threaten its viability
March 24, 2025: Registration Opens for Pragmatic Trials Workshop at SCT 46th Annual Meeting
Rethinking Clinical Trials
MARCH 24, 2025
The NIH Pragmatic Trials Collaboratory will offer a preconference workshop at the Society for Clinical Trials 46th Annual Meeting in Vancouver. Registration for the workshop is now open. The half-day workshop, “Getting Robust Answers to Meaningful Questions: Essentials of Embedded Pragmatic Clinical Trials,” will introduce concepts in the design, conduct, and implementation of pragmatic clinical trials embedded in healthcare systems, with a particular focus on engaging healthcare sys
Why AI and ethics are needed for the future of pharma investment
pharmaphorum
MARCH 24, 2025
Explore the importance of incorporating AI and ethics in pharmaceutical investment for the future. Learn about the impact and benefits of these technologies in the industry.
Parkinson’s Gut Bacteria Link Suggests an Unexpected, Simple Treatment
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 24, 2025
Illustration of bacteria on the colon epithelium. (Nanoclustering/Science Photo Library/Getty Images) Researchers have suspected for some time that the link between our gut and brain plays a role in the development of Parkinson’s disease.
Augustine decloaks with $85m for nerve disease programme
pharmaphorum
MARCH 24, 2025
Belgian startup Augustine raises 78m ($85m) in first-round funding for HDAC6 inhibitors headed by a candidate for Charcot-Marie-Tooth disease.
TN CDA seeks CM intervention to stop discount pharmacies to prevent entry of counterfeit drugs into the market
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 24, 2025
The Chemists and Druggists Association in Tamil Nadu (TN CDA) has written a letter to chief minister MK Stalin seeking his immediate intervention to curb the entry of counterfeit and spurious medicines into the market by way of excessive discount offers by marketing companies to incentivise retail chemists.
The role of NHS Big Data and AI technology in unlocking the future of lung and heart disease treatment
pharmaphorum
MARCH 24, 2025
The role of NHS Big Data and AI technology in unlocking the future of lung and heart disease treatment Mike.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Schedule III Marijuana Would Still Be Regulated Marijuana
FDA Law Blog
MARCH 24, 2025
By Larry K. Houck In August 2023, the U.S. Department of Health and Human Services (HHS), based on the federal Controlled Substances Acts (CSAs) Eight Factor Analysis, recommended that the Drug Enforcement Administration (DEA) reschedule marijuana from schedule I to schedule III. The U.S. Department of Justice subsequently conducted a separate Eight Factor Analysis and concurred with HHS rescheduling recommendation.
6th GxP Cloud Compliance Summit 2025
pharmaphorum
MARCH 24, 2025
6th GxP Cloud Compliance Summit 2025 Sara.
Hubs East 2025: The Patient Access Landscape
Pharmaceutical Commerce
MARCH 24, 2025
A Day 3 presentation dives into the impact of copay accumulators, maximizers, and AFPs on driving cost savings.
2nd ESG in Life Sciences Summit Europe
pharmaphorum
MARCH 24, 2025
2nd ESG in Life Sciences Summit Europe Sara.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Let's personalize your content